Science Driven
Utilizing the expertise of our medicinal chemistry and biology teams, we target liver and viral diseases with a need for better efficacy. Applying this strong scientific foundation, we have built a differentiated pipeline of best-in-class therapies.
Learn about chronic HBV infection and our approach
FOCUSED APPROACH
Our highly experienced team has had multiple successes from discovery through commercialization in the fields of hepatology and virology.
PATIENT CENTRIC
We have purpose-built drugs with enhanced pharmacologic properties for large unmet medical needs in liver and viral diseases where better therapies will greatly impact patients.
Pevifoscorvir sodium
Our oral small molecule capsid assembly modulator (CAM-E) under development for chronic hepatitis B virus infection (HBV).
ALG-170675
Our next-generation antisense oligonucleotide (ASO) under development for chronic hepatitis B virus infection (HBV).